1Reaven GM. Banting Lecture 1988: Role of the insulin resistance in human disease. Diabetes, 1988,37 : 1495
2Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med, 1999,16 : 442
3Einhorn D, Reaven GM, Cobin RH, et al. American college of endocrinology position statement on the insulin resistance syndrome. Endocr Pract, 2003 ,9 : 237
1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.
4Ford ES,Giles WH,Dietz WH.Prevalence of the metabolic syndrome among US adults:findings from the third National Health and Nutration Examination Survey[J].JAMA,2002,287(3):356-359.
5Azizi F,Salehi P,Etemadi A,et al.Prevalence of metabolic syndrome in a urban population:Tehran Lipid and Glucose Study[J].Diabetes Res Clin Pract,2003,6l(1):29-37.
6Misra A.Vikram NK.Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians:evidence and implications[J].Nutrition,2004,20 (5):482-491.
7Hanley AJ,Williams K,Sttern MP,et al.Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease:the San Antonio Heart Study[J].Diabetes Care,2002,25(7):1177-1184.
8Ginsberg HN,Huang LS.The insulin resistance syndrome:impact on lipo protein Metabolism and atherothrombosis[J].J Cardiovasc Risk,2000,7(5):325-331.
